(3
S
, 9
R
)- and (3
S
, 9
S
)-Megastigma-6,7-dien-3,5,9-triol 9-
O
-
b
-
D
-glucopyranosides in Rose Flowers
2695
Shizuoka University (Japan) in 2000. The frozen
‰owers (10 kg) were extracted by 70 MeOH under
ice-cooling, and the extract was loaded into a column
of Amberlite XAD-2 (120 660 mm, Vt 7500 ml)
that has been equilibrated with water and developed
with MeOH to give a progenitor fraction. After con-
centration, the MeOH extract was acetylated
(pyridine-acetic anhydride) and puriˆed by ‰ash
chromatography on an LP-75 silica gel cartridge
partially puriˆed by preparative silica gel TLC
=
z
(CH2Cl2:hexane:EtOAc 6:2.5:1.5) to give the (3
S,
9
S
)- and (3 , 9 )-diastereomers. These were treated
S
R
×
=
・
with LiOH H2O in the usual manner and further
puriˆed by HPLC (MeCN-water, YMC pack ODS-
×
AQ, 20 250 mm) to give (3
0.75 yield) and (3 , 9 )-2b (3.2 mg, 2.9z
S
, 9
S
)-2b (0.8 mg,
yield).
z
S
R
Spectral data:
3-O-Acetyl-megastigma-6,7-diene-3,5,9-triol (3-O-
acetyl-2a). 1H-NMR (270 MHz, CDCl3)
: 1.08, 1.10
6.6 Hz, H-10),
1.36 (3H, s, H-13), 1.37 (1H, overlapped with H-13,
H-2ax), 1.38, 1.39 (each 3 2H, s, H-12), 1.47 (1H,
(75
×
300 mm, Vt
=
1325 ml; Wako, Japan; hexane-
=
EtOAc 8:2–3:7 v v) to yield eight fractions.
d
W
=
(each 3 2H, s, H-11), 1.30 (3H, d, J
To detect the progenitors, a portion (10–20 g fr.
wt. eq.) of each fraction was deacetylated by treating
W
with MeONa and then heated at 909C for 2 h at pH 2
W
in a sealed tube.6,7) The volatile compounds formed
were extracted by an azeotropic mixture of pentane-
CH2Cl2 (2:1) under neutral conditions and analyzed
by GC-MS. Two desired fractions were separately
further puriˆed by silica gel ‰ash chromatography on
dd,
J 12.9, 8.8 Hz, H-4ax), 1.96 (1H, ddd, J 2.3,
= =
4.2, 12.2 Hz, H-2eq), 2.03 (3H, s, acetate), 2.25 (1H,
=
2.3, 4.2, 12.9 Hz, H-4eq), 4.33 (1H, m,
ddd,
H-9), 5.33 (1H, m, H-3), 5.41 (1H, d,
H-8); 13C-NMR (67.5 MHz, CDCl3)
: 23.3 (C10),
J
=
J
5.7 Hz,
d
an LP-40 cartridge (40
×
=
150 mm, Vt
=
188 ml; hex-
29.2 (C12), 31.2 (C13), 32.2 (C11), 35.1 (C1), 45.1,
(C4), 45.3 (C2), 66.3 (C3), 67.9 (C9), 72.9 (C5), 100.1
(C8), 117.5 (C6), 197.6 (C7), 21.4 and 170.5
(acetate).
ane-
t-butyl methyl ether 9:1–3:7 v v) and then by
W
×
HPLC (column: ODS-AM 20 250 mm, YMC,
Japan; solvent: MeCN-water 50:50–75:25 v v) to
W
give four progenitor fractions. Compound 4b
(1.2 mg) was isolated from one of the less-polar frac-
tions as its pentaacetate.
(3S, 9S)-megastigma-6,7-diene-3,5,9-triol 9-O-
glucopyranoside ((3S, 9S)-2b). 1H-NMR (500 MHz,
D2O) : 1.07 (3H, s, H-11), 1.26 (3H, s, H-12), 1.32
(1H, dd, 11.9, 8.9 Hz, H-2ax), 1.36 (3H, d,
b
-
D
-
d
3,2
7,8-didehydro-
(3,2 ,3 ,4 ,6
-penta-O-acetyl-(3R, 9R)-4b). 13C-NMR
(125 MHz, CDCl3) : 22.3 (CH3-C5), 23.1 (CH3-C9),
28.5 (CH3-C1), 30.1 (CH3-C1), 35.9 (C1), 37.3 (C4),
42.1 (C2), 62.0 (C6 ), 67.5 (C9), 67.8 (C3), 68.4
(C4 ), 71.8 (C2 ), 71.9 (C5 ), 73.0 (C3 ), 84.0 (C7),
91.9 (C8), 98.9 (C1 ), 123.2 (C6), 137.9 (C5),
20.6–21.4 (CH3 5 of acetyl group), 169.3–170.7 (C
?
,3
?
,4
?
,6
?
-penta-O-acetyl-(3R, 9R)-3-hydroxy
J
=
D
J
=
6.4 Hz, H-10), 1.41 (1H, dd,
J
=
12.0, 8.8 Hz, H-
b
-ionol 9-O- -glucopyranoside
b
-
?
?
?
?
4ax), 1.41 (3H, s, H-13), 1.89 (1H, ddd,
11.9 Hz, H-2eq), 2.16 (1H, ddd,
J
=
2.0, 4.5,
=
d
J
2.0, 4.5,
=
8.5 Hz, H-2?), 3.33
12.0 Hz, H-4eq), 3.27 (1H, t,
(1H, ddd, 1.2, 5.8, 8.8 Hz, H-5
8.5, 8.8 Hz, H-4 ), 3.45 (1H, dd,
H-3 ), 3.70 (1H, dd, 5.8, 12.5 Hz, H-6
(1H, dd, 1.5, 12.5 Hz, H-6 b), 4.21 (1H, m, H-3),
4.54 (1H, m, H-9), 4.64 (1H, d,
5.29 (1H, d,
8.0 Hz, H-8); 13C-NMR (125 MHz,
D2O) : 23.7 (C10), 30.9 (C12), 33.1 (C13), 34.6
(C11), 37.3 (C1), 50.1 (C4), 50.4 (C2), 63.6 (C6 ),
66.7 (C3), 71.3 (C4 ), 74.7 (C5), 75.8 (C2 ), 76.8
(C9), 78.7 (C3 ), 78.9 (C5 ), 98.5 (C8), 101.9 (C1 ),
J
?
J
=
?), 3.37 (1H, dd,
=
=
?
?
?
?
J
?
J
8.9, 8.5 Hz,
a), 3.89
?
?
J
=
?
×
=
J
?
= ×
O
=
8.3 Hz, H-1
5 of acetyl group). All the signals were as-
J
?),
signed based on the 1H–1H-COSY, HMQC, and
HMBC spectra.12,17)
J
=
d
?
Synthesis of (3S, 9S)- and (3S, 9R)-megastigma-
?
?
6,7-diene-3,5,9-triol 9-O-
b
-
D
-glucopyranosides ((3S,
-acetyl-
?
?
?
9S)- and (3S, 9R)-2b). To a solution of 3-
O
117.9 (C6), 203.2 (C7); FABMS (negative ion,
grasshopper ketone, which had been prepared
according to the literature method,18) (96 mg,
0.36 mmole) in 3 ml of MeOH was added NaBH4
(38 mg, 1.0 mmole), and the mixture stirred for
glycerol) m z 387 (M„H)„; [
a
]2D7„29.1
9
(
c
1.00,
W
MeOH).
(3S, 9R)-megastigma-6,7-diene-3,5,9-triol 9-O-
-glucopyranoside ((3S, 9R)-2b). 1H-NMR (500
MHz, D2O) : 1.10 (3H, s, H-11), 1.24 (3H, s,
H-12), 1.29 (1H, dd,
b-
30 min to give 3-
3,5,9-triol (3- -acetyl-2a; 81 mg, 0.30 mmole, 83
-Acetyl-2a (76 mg, 0.28 mmole) was
with 2,3,4,6-tetra- -pivaloyl- -gluco-
O
-acetyl-megastigma-6,7-diene-
D
O
z
d
=
yield). 3-
stirred
O
J
11.5, 9.2 Hz, H-2ax), 1.32
=
J
O
D
(3H, d,
(1H, dd,
2.3, 4.2, 11.5 Hz, H-2eq), 2.15 (1H, dd, J
=
6.1 Hz, H-10), 1.36 (3H, s, H-13), 1.42
=
pyranosyl bromide (489 mg, 0.84 mmole) and
tetramethylurea (252 mg, 2.2 mmole) in dry CH2Cl2
J
11.9, 8.8 Hz, H-4ax), 1.89 (1H, dd,
2.3,
8.2 Hz, H-2 ),
1.2, 4.6, 7.9 Hz, H-5 ), 3.37 (1H,
7.5, 7.9 Hz, H-4 ), 3.39 (1H, t,
J
=
=
at 0
9C for 1 h in the presence of molecular sieves
4.2, 13.2 Hz, H-4eq), 3.23 (1H, t,
J
?
=
4A (2 g). To this solution, silver tri‰uoroacetate
(292 mg, 1.0 mmole) was added, and the solution
3.33 (1H, ddd,
J
?
=
=
dd,
H-3
(1H, dd,
J
?
J
7.5 Hz,
=
4.6, 12.2 Hz, H-6?a), 3.88
further stirred for 5.5 hours at 0
9
C. The diastereo-
?
), 3.71 (1H, dd,
J
meric mixture of tetra- -pivaloyl-2b obtained was
O
J
=
1.2, 12.2 Hz, H-6?b), 4.20 (1H, m, H-3),